Mus musculus Protein: Nfkb2 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-257180.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | Nfkb2 | ||||||||||||||||||||||
Protein Name | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | ||||||||||||||||||||||
Synonyms | lyt; NF-kappaB2; p49; p49/p100; p50B; p52; | ||||||||||||||||||||||
Species | Mus musculus | ||||||||||||||||||||||
Ensembl Protein | ENSMUSP00000107512 | ||||||||||||||||||||||
InnateDB Gene | IDBG-172544 (Nfkb2) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14- activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65 (By similarity). In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. {ECO:0000250, ECO:0000269PubMed:22894897}. | ||||||||||||||||||||||
Subcellular Localization | Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). {ECO:0000250}. | ||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||
Tissue Specificity | Highly expressed in lymph nodes and thymus. {ECO:0000269PubMed:10398801}. | ||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 30 experimentally validated interaction(s) in this database.
They are also associated with 133 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | MGI:1099800 | ||||||||||||||||||||||
InterPro |
IPR000451
NF-kappa-B/Rel/Dorsal IPR000488 Death domain IPR002110 Ankyrin repeat IPR002909 IPT domain IPR008967 p53-like transcription factor, DNA-binding IPR011029 Death-like domain IPR011539 Rel homology domain IPR014756 Immunoglobulin E-set IPR020683 Ankyrin repeat-containing domain |
||||||||||||||||||||||
PFAM |
PF00531
PF00023 PF13606 PF01833 PF00554 PF11929 PF12796 |
||||||||||||||||||||||
PRINTS |
PR00057
PR01415 |
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM00005
SM00248 SM00429 |
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | Q9WTK5 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q9WTK5 | ||||||||||||||||||||||
TrEMBL | Q3UG25 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 18034 | ||||||||||||||||||||||
UniGene | Mm.102365 | ||||||||||||||||||||||
RefSeq | NP_062281 | ||||||||||||||||||||||
MGI ID | 3JV6 | ||||||||||||||||||||||
MGI Symbol | Nfkb2 | ||||||||||||||||||||||
OMIM | |||||||||||||||||||||||
CCDS | CCDS29874 | ||||||||||||||||||||||
HPRD | |||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AF135125 AF155372 AF155373 AK144994 AK148160 AK150012 BC027423 | ||||||||||||||||||||||
GenPept | AAD39462 AAD39546 AAD39547 AAH27423 BAE26174 BAE28384 BAE29237 | ||||||||||||||||||||||